WAY-278752 is primarily used in scientific research to investigate the role of serotonin receptors, particularly the 5-HT6 receptor subtype, in neurological and cognitive functions. It acts as a selective antagonist or modulator at these receptors, making it a valuable tool for studying conditions such as Alzheimer's disease, schizophrenia, and other cognitive disorders. Researchers use WAY-278752 to explore how modulation of the 5-HT6 pathway affects memory, learning, and behavior in preclinical models. Its application is confined to laboratory and experimental settings, aiding in the development of potential therapeutics targeting central nervous system disorders.